Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea

Author: Tae-Geun GWEON ¹ ; Yoo Jin LEE ; Kyeong Ok KIM ; Sung Kyun YIM ; Jae Seung SOH ; Seung Young KIM ; Jae Jun PARK ; Seung Yong SHIN ; Tae Hee LEE ; Chang Hwan CHOI ; Young-Seok CHO ; Dongeun YONG ; Jin-Won CHUNG ; Kwang Jae LEE ; Oh Young LEE ; Myung-Gyu CHOI ; Miyoung CHOI ; Gut Microbiota and Therapy Research Group Under the Korean Society of Neurogastroenterology and Moti
Author Information

1. Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
Publication Type:Review
From:Journal of Neurogastroenterology and Motility 2022;28(1):28-42
CountryRepublic of Korea
Language:English
Abstract: Fecal microbiota transplantation (FMT) is a highly efficacious and safe modality for the treatment of recurrent or refractory Clostridioides difficile infection (CDI), with overall success rates of 90%. Thus, FMT has been widely used for 10 years. The incidence and clinical characteristics of CDI, the main indication for FMT, differ between countries. To date, several guidelines have been published. However, most of them were published in Western countries and therefore cannot represent the Korean national healthcare systems. One of the barriers to performing FMT is a lack of national guidelines. Accordingly, multidisciplinary experts in this field have developed practical guidelines for FMT. The purpose of these guidelines is to aid physicians performing FMT, which can be adapted to treat CDI and other conditions.